Advances research in third generation aromatase inhibitors in adjuvant therapy of postmenopausal women with early breast cancer
- VernacularTitle:第三代芳香化酶抑制剂在乳腺癌术后辅助治疗中的应用进展
- Author:
Binghe XU
- Publication Type:Journal Article
- Keywords:
breast neoplasms;
adjuvant therapy;
aromatase inhibitors
- From:
China Oncology
1998;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Recent data of third generation aromatase inhib itors in adjuvant endocrine therapy of postmenopausal women with early breast ca ncer were reviewed in this article. Aromatase inhibitors, especially anastozole, may be the first to become the new standard adjuvant endocrine therapy in opera ble breast cancer patients instead of tamoxifen.